BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19059574)

  • 1. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system.
    Le Heuzey JY; Marijon E; Chachoua K; Waintraub X; Lepillier A; Otmani A; Lavergne T; Pornin M
    Arch Cardiovasc Dis; 2008; 101(11-12):787-91. PubMed ID: 19059574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
    Boos CJ; Lip GY
    J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
    Lau YF; Yiu KH; Siu CW; Tse HF
    J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of renin-angiotensin system inhibitors in atrial fibrillation.
    Disertori M; Latini R; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
    Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
    Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation--a complication in hypertension].
    Ukena CV; Neuberger HR; Böhm M
    MMW Fortschr Med; 2011 Oct; 153(41):47-8. PubMed ID: 22046841
    [No Abstract]   [Full Text] [Related]  

  • 9. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of lipid lowering therapy and renin angiotensin blockade in outcomes of patients with atrial fibrillation.
    Badheka AO; Tuliani T; Rathod A; Shenoy M; Afonso L; Jacob S
    Am J Cardiol; 2012 Apr; 109(8):1238. PubMed ID: 22464019
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation in essential hypertension: an issue of concern.
    Zhao LQ; Liu SW
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):100-6. PubMed ID: 24553088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2003; 119(16):1505-7. PubMed ID: 14535023
    [No Abstract]   [Full Text] [Related]  

  • 15. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
    Nattel S
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
    Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
    Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A link between hypertension and atrial fibrillation: methods of treatment and prevention.
    Aksnes TA; Kjeldsen SE
    Curr Vasc Pharmacol; 2010 Nov; 8(6):769-74. PubMed ID: 20626338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.